
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 136
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT02440789 | Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) | ||
NCT01400412 | Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen | ||
NCT06205589 | Therapeutic ID93 + GLA-SE Vaccination in Participants with Rifampicin-Susceptible Pulmonary TB | ||
NCT00442962 | HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV | ||
NCT01641367 | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure | ||
NCT01380080 | REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment | ||
NCT00108862 | Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis | ||
NCT00051831 | Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults | ||
NCT02582073 | Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ | ||
NCT01632891 | Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected | ||
NCT01928927 | Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) | ||
NCT00417573 | Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections | ||
NCT01903031 | Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART | ||
NCT01936831 | High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) | ||
NCT00537394 | Optimizing Treatment for Treatment-Experienced, HIV-Infected People | ||
NCT02042248 | A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004 | ||
NCT01601626 | Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV | ||
NCT02840474 | Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults | ||
NCT00361257 | Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults | ||
NCT00100867 | Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women | ||
NCT02605304 | 12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF | ||
NCT00608569 | Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults | ||
NCT00830804 | Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults | ||
NCT04042740 | Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection | ||
NCT00086372 | Long-term Follow-up of HIV Infected Patients Identified During Early Infection | ||
NCT00959413 | Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load | ||
NCT01435018 | Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS | ||
NCT02128217 | Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection | ||
NCT00414141 | Efficacy and Safety/Tolerability of Grass MATA MPL | ||
NCT00084136 | Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings | ||
NCT06729606 | Aviptidil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) | ||
NCT05455749 | Effect of holoBLG on Cat Allergic Patients | ||
NCT04050449 | Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD | ||
NCT01515813 | Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation | ||
NCT01029249 | Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults | ||
NCT02412436 | PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB | ||
NCT00393276 | Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals | ||
NCT01426438 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | ||
NCT00031408 | Consent for Use of Stored Patient Specimens for Future Testing | ||
NCT00090779 | Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV | ||
NCT01427738 | Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis | ||
NCT00325338 | Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis | ||
NCT03819114 | Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy | ||
NCT00096850 | Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults | ||
NCT03070223 | PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) | ||
NCT04860323 | Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study | ||
NCT04518410 | ACTIV-2: A Study for Outpatients With COVID-19 | ||
NCT00104390 | Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing | ||
NCT00819390 | Chloroquine for Reducing Immune Activation in HIV- Infected Individuals | ||
NCT00118612 | Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen |